Ameritas Investment Partners, Inc. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 135 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$197,592
-24.0%
1,353
+20.3%
0.01%
-20.0%
Q2 2023$259,875
+8.4%
1,125
+13.6%
0.01%
+11.1%
Q1 2023$239,837
-16.3%
990
+5.3%
0.01%
-18.2%
Q4 2022$286,644
+402.9%
940
+5.6%
0.01%
+266.7%
Q3 2022$57,000
-9.5%
8900.0%0.00%0.0%
Q2 2022$63,000
-27.6%
8900.0%0.00%0.0%
Q1 2022$87,000
+16.0%
8900.0%0.00%0.0%
Q4 2021$75,000
+5.6%
8900.0%0.00%0.0%
Q3 2021$71,000
-18.4%
8900.0%0.00%0.0%
Q2 2021$87,000
-5.4%
890
+13.1%
0.00%
-25.0%
Q1 2021$92,000
+5.7%
7870.0%0.00%0.0%
Q4 2020$87,000
-6.5%
7870.0%0.00%0.0%
Q3 2020$93,000
+4.5%
7870.0%0.00%0.0%
Q2 2020$89,000
+93.5%
787
+14.6%
0.00%
+33.3%
Q1 2020$46,000
-27.0%
6870.0%0.00%0.0%
Q4 2019$63,000
+21.2%
687
+14.9%
0.00%
+50.0%
Q3 2019$52,000
-17.5%
5980.0%0.00%
-33.3%
Q2 2019$63,000
-16.0%
5980.0%0.00%0.0%
Q1 2019$75,000
+11.9%
5980.0%0.00%
-25.0%
Q4 2018$67,000
-47.7%
5980.0%0.00%
-33.3%
Q3 2018$128,000
-10.5%
598
+16.8%
0.01%
-14.3%
Q2 2018$143,000
+248.8%
512
+44.2%
0.01%
+250.0%
Q1 2018$41,000
+24.2%
3550.0%0.00%0.0%
Q4 2017$33,000
+450.0%
3550.0%0.00%
Q3 2017$6,0000.0%3550.0%0.00%
Q2 2017$6,0003550.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders